A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
NCT05027308
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class
Conditions
Short Bowel Syndrome
Interventions
DRUG:
Teduglutide
Sponsor
Takeda